StockSelector.com
  Research, Select, & Monitor Friday, May 24, 2019 1:33:40 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aratana Therapeutics Inc$4.79($.01)(.21%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aratana Therapeutics Inc has an overall rank of 2971 out of 6961 stocks based on 8 positive rankings and 11 negative rankings.

Positive Rankings
Historic Revenue Growth
Aratana Therapeutics Inc rank is 14
Debt-to-Equity
Aratana Therapeutics Inc rank is 108
Estimated Revenue Growth
Aratana Therapeutics Inc rank is 180
PEGValue
Aratana Therapeutics Inc has a PEG Value of $15.23. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 217.31% in the next year. Among companies with a PEG Value above the current stock price, Aratana Therapeutics Inc is ranked 201.
Low Put/Call
Aratana Therapeutics Inc has a low Put/Call ratio of 0.13 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aratana Therapeutics Inc is ranked 330.
Low vPut/Call
Aratana Therapeutics Inc has a low Put/Call ratio of 0.35 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aratana Therapeutics Inc is ranked 677.
SSValue
The StockSelector Value for Aratana Therapeutics Inc is $7.40. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Aratana Therapeutics Inc is ranked 856.
90 Day Gain
Aratana Therapeutics Inc rank is 888
Negative Rankings
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Aratana Therapeutics Inc is ranked 282.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Aratana Therapeutics Inc is ranked 534.
Negative Net Margin
Aratana Therapeutics Inc rank is 659
Price-to-Sales
Aratana Therapeutics Inc rank is 770
Negative Cash Growth
Aratana Therapeutics Inc rank is 976
Negative ROA
Aratana Therapeutics Inc rank is 1048
Negative ROE
Aratana Therapeutics Inc rank is 1065
Down EPS Surprise
Aratana Therapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Down EPS Surprise
Aratana Therapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
Aratana Therapeutics Inc rank is 1865
10 Day Loss
Aratana Therapeutics Inc rank is 2718







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.